Search Results

There are 19899 results for: content related to: Expression of Fas and Fas ligand in primary cutaneous squamous cell carcinoma in association with grade of tumor differentiation

  1. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status

    The Journal of Pathology

    Volume 201, Issue 1, September 2003, Pages: 46–54, Julie M Michael-Robinson, Nirmala Pandeya, Margaret C Cummings, Michael D Walsh, Joanne P Young, Barbara A Leggett, David M Purdie, Jeremy R Jass and Graham L Radford-Smith

    Version of Record online : 30 MAY 2003, DOI: 10.1002/path.1406

  2. miR-21 represses FasL in microglia and protects against microglia-mediated neuronal cell death following hypoxia/ischemia


    Volume 60, Issue 12, December 2012, Pages: 1888–1895, Li Zhang, Lian-Yan Dong, Ya-Jian Li, Zhen Hong and Wen-Shi Wei

    Version of Record online : 20 AUG 2012, DOI: 10.1002/glia.22404

  3. Expression of Fas ligand is an early event in colorectal carcinogenesis

    Journal of Surgical Oncology

    Volume 76, Issue 1, January 2001, Pages: 63–68, Masaaki Shimoyama, Tatsuo Kanda, Lili Liu, Yu Koyama, Takeyasu Suda, Yasuo Sakai and Katsuyoshi Hatakeyama

    Version of Record online : 31 JAN 2001, DOI: 10.1002/1096-9098(200101)76:1<63::AID-JSO1011>3.0.CO;2-C

  4. You have free access to this content
    Listeria monocytogenes virulence proteins induce surface expression of Fas ligand on T lymphocytes

    Molecular Microbiology

    Volume 51, Issue 5, March 2004, Pages: 1483–1492, Lauren A. Zenewicz, Jason A. Skinner, Howard Goldfine and Hao Shen

    Version of Record online : 4 FEB 2004, DOI: 10.1111/j.1365-2958.2003.03931.x

  5. Pre-existing fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of FasL expression after inoculation facilitates tumor formation

    Molecular Carcinogenesis

    Volume 52, Issue 9, September 2013, Pages: 705–714, Hsiao-Ying Chiu, Guang-Huan Sun, Shiow-Yi Chen, Hsiao-Hsien Wang, Ming-Yi Ho, Chia-Yi Chu, Wan-Lin Wu, Ren-Shiang Jhou, Yi-Lin Tsai, Rui-Ting Huang, Kuang-Hui Sun and Shye-Jye Tang

    Version of Record online : 9 APR 2012, DOI: 10.1002/mc.21909

  6. You have free access to this content
    The regulation of FasL expression during activation-induced cell death (AICD)


    Volume 103, Issue 4, August 2001, Pages: 426–434, Thang Nguyen and John Russell

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1365-2567.2001.01264.x

  7. You have free access to this content
    Synergistic action of protein kinase C θ and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells

    European Journal of Immunology

    Volume 29, Issue 11, November 1999, Pages: 3549–3561, Andreas Villunger, Nassim Ghaffari-Tabrizi, Inge Tinhofer, Nina Krumböck, Birgit Bauer, Thomas Schneider, Shailaja Kasibhatla, Richard Greil, Gabriele Baier-Bitterlich, Florian Überall, Douglas R. Green and Gottfried Baier

    Version of Record online : 25 OCT 1999, DOI: 10.1002/(SICI)1521-4141(199911)29:11<3549::AID-IMMU3549>3.0.CO;2-Q

  8. You have free access to this content
    Fas Ligand as a Tool for Immunosuppression and Generation of Immune Tolerance


    Volume 22, Issue 6, November 2004, Pages: 908–924, Osnat Bohana-Kashtan and Curt I. Civin

    Version of Record online : 1 NOV 2004, DOI: 10.1634/stemcells.22-6-908

  9. Clinicopathologic Analysis of Fas, Fas Ligand, and Other Biomarkers in Locally Advanced Breast Carcinoma

    The Breast Journal

    Volume 6, Issue 4, July 2000, Pages: 233–241, Nat L. Pernick, Laura Biernat, Wei Du and Daniel W. Visscher

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1524-4741.2000.98087.x

  10. You have free access to this content
    NF-κB-dependent Fas ligand expression

    European Journal of Immunology

    Volume 29, Issue 9, September 1999, Pages: 2948–2956, Shu-Ching Hsu, Mikhail A. Gavrilin, Hsiu-Hsiang Lee, Chia-Cheng Wu, Shou- Hwa Han and Ming-Zong Lai

    Version of Record online : 15 SEP 1999, DOI: 10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO;2-0

  11. A vision of cell death: insights into immune privilege

    Immunological Reviews

    Volume 156, Issue 1, April 1997, Pages: 167–184, Thomas A. Ferguson and Thomas S. Griffith

    Version of Record online : 28 APR 2006, DOI: 10.1111/j.1600-065X.1997.tb00967.x

  12. You have free access to this content
    Fas ligand plays an important role for the production of pro-inflammatory cytokines in intervertebral disc nucleus pulposus cells

    Journal of Orthopaedic Research

    Volume 31, Issue 4, April 2013, Pages: 608–615, Junya Yamamoto, Koichiro Maeno, Toru Takada, Kenichiro Kakutani, Takashi Yurube, Zhongying Zhang, Hiroaki Hirata, Takuto Kurakawa, Daisuke Sakai, Joji Mochida, Minoru Doita, Masahiro Kurosaka and Kotaro Nishida

    Version of Record online : 28 NOV 2012, DOI: 10.1002/jor.22274

  13. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma

    The Journal of Pathology

    Volume 201, Issue 2, October 2003, Pages: 268–277, Isabelle Viard-Leveugle, Sylvie Veyrenc, Lars E French, Christian Brambilla and Elisabeth Brambilla

    Version of Record online : 1 JUL 2003, DOI: 10.1002/path.1428

  14. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma

    British Journal of Dermatology

    Volume 151, Issue 1, July 2004, Pages: 42–49, A.C. Satchell, R.StC. Barnetson and G.M. Halliday

    Version of Record online : 9 JUL 2004, DOI: 10.1111/j.1365-2133.2004.05974.x

  15. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death

    European Journal of Immunology

    Volume 27, Issue 8, August 1997, Pages: 1858–1864, Norihiko Watanabe, Hisashi Arase, Kazuhiro Kurasawa, Itsuo Iwamoto, Nobuhiko Kayagaki, Hideo Yagita, Ko Okumura, Shoichiro Miyatake and Takashi Saito

    Version of Record online : 7 DEC 2005, DOI: 10.1002/eji.1830270807

  16. You have free access to this content
    Inhibition of FAS/FAS ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-FAS ligand autoantibodies in patients with systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 41, Issue 2, February 1998, Pages: 344–353, Noboru Suzuki, Motohide Ichino, Shoji Mihara, Sakae Kaneko and Tsuyoshi Sakane

    Version of Record online : 28 MAY 2004, DOI: 10.1002/1529-0131(199802)41:2<344::AID-ART19>3.0.CO;2-J

  17. You have free access to this content
    The role of Fas ligand and transforming growth factor β in tumor progression


    Volume 100, Issue 11, 1 June 2004, Pages: 2281–2291, Ryungsa Kim, Manabu Emi, Kazuaki Tanabe, Yoko Uchida and Tetsuya Toge

    Version of Record online : 28 APR 2004, DOI: 10.1002/cncr.20270

  18. You have free access to this content
    Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing


    Volume 141, Issue 2, February 2014, Pages: 242–255, Liboria Siena, Elisabetta Pace, Maria Ferraro, Caterina Di Sano, Mario Melis, Mirella Profita, Mario Spatafora and Mark Gjomarkaj

    Version of Record online : 9 JAN 2014, DOI: 10.1111/imm.12190

  19. You have free access to this content
    Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals

    Clinical & Experimental Immunology

    Volume 121, Issue 3, September 2000, Pages: 515–522, C. Odaka and T. Mizuochi

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2249.2000.01323.x

  20. You have free access to this content
    Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas

    International Journal of Cancer

    Volume 81, Issue 5, 31 May 1999, Pages: 772–778, Lucie Peduto Eberl, Louis Guillou, Emilia Saraga, Michael Schröter, Lars E. French, Jürg Tschopp and Lucienne Juillerat-Jeanneret

    Version of Record online : 8 NOV 1999, DOI: 10.1002/(SICI)1097-0215(19990531)81:5<772::AID-IJC18>3.0.CO;2-S